Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Non Operating Income: 2023-2024

Historic Non Operating Income for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Dec 2024 value amounting to -$2.1 million.

  • Tonix Pharmaceuticals Holding's Non Operating Income fell 2527.27% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.2 million, marking a year-over-year decrease of 240.13%. This contributed to the annual value of -$2.1 million for FY2024, which is 220.73% down from last year.
  • Latest data reveals that Tonix Pharmaceuticals Holding reported Non Operating Income of -$2.1 million as of FY2024, which was down 220.73% from $1.7 million recorded in FY2023.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Non Operating Income registered a high of $1.7 million during FY2023, and its lowest value of -$2.1 million during FY2024.
  • In the last 2 years, Tonix Pharmaceuticals Holding's Non Operating Income had a median value of -$178,500 in 2023 and averaged -$178,500.
  • Data for Tonix Pharmaceuticals Holding's Non Operating Income shows a maximum YoY tumbled of 220.73% (in 2024) over the last 5 years.
  • Tonix Pharmaceuticals Holding's Non Operating Income (Yearly) stood at $1.7 million in 2023, then plummeted by 220.73% to -$2.1 million in 2024.